Literature DB >> 33325788

Association Between Vitamin D Deficiency and COVID-19 Incidence, Complications, and Mortality in 46 Countries: An Ecological Study.

Javier Mariani1, Virna Margarita Marín Giménez1, Ivana Bergam1, Carlos Tajer1, Laura Antonietti1, Filipe Inserra1, León Ferder1, Walter Manucha1.   

Abstract

Each patient's immune defenses play a major role in mitigating the impact (ie, morbidity and mortality) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for coronavirus disease 2019 (COVID-19). Vitamin D is an important modulator of the immune system. Although serum 25-hydroxyvitamin D levels can be raised through diet or supplements, most vitamin D in the body is the result of dermal synthesis from ultraviolet radiation. The production of vitamin D in the skin, however, can be limited by latitude, skin-covering clothes, the use of sunblock, and skin pigmentation. Vitamin D deficiency affects a high percentage of the world population. Serum 25-hydroxyvitamin D levels are suboptimal, not only in specific risk groups but also in adults from many countries. Low vitamin D levels, therefore, represent a risk factor for several different pathologies, including SAR-CoV-2. This study used an ecological design to assess the association between vitamin D deficiency and COVID-19 incidence, complications, and mortality across 46 countries. All data were obtained from published sources. The results of the study suggest an association at the population level between the prevalence of vitamin D deficiency and the risk of being infected with COVID-19, severity of the disease, and risk of dying from it.

Entities:  

Keywords:  COVID-19; Infectious disease; Public health preparedness/response; SARS; Vitamin D

Mesh:

Substances:

Year:  2020        PMID: 33325788     DOI: 10.1089/hs.2020.0137

Source DB:  PubMed          Journal:  Health Secur        ISSN: 2326-5094


  21 in total

1.  Comparison of COVID-19 Resilience Index and Its Associated Factors across 29 Countries during the Delta and Omicron Variant Periods.

Authors:  Le Duc Huy; Chung-Liang Shih; Yao-Mao Chang; Nhi Thi Hong Nguyen; Phan Thanh Phuc; Tsong-Yih Ou; Chung-Chien Huang
Journal:  Vaccines (Basel)       Date:  2022-06-13

Review 2.  Calcifediol for Use in Treatment of Respiratory Disease.

Authors:  Marta Entrenas-Castillo; Lourdes Salinero-González; Luis M Entrenas-Costa; Rubén Andújar-Espinosa
Journal:  Nutrients       Date:  2022-06-13       Impact factor: 6.706

Review 3.  Vitamin D for Recovery of COVID-19 in Patients With Chronic Kidney Disease.

Authors:  Wen-Fang Chiang; Po-Jen Hsiao; Jenq-Shyong Chan
Journal:  Front Nutr       Date:  2022-06-15

4.  The Covid-19 infection: An opportunity to develop systematic vitamin D supplementation in psychiatry.

Authors:  G Fond; M Masson; R Richieri; T Korchia; D Etchecopar-Etchart; P-L Sunhary de Verville; C Lançon; L Boyer
Journal:  Encephale       Date:  2021-03-14       Impact factor: 1.291

5.  Melatonin may decrease risk for and aid treatment of COVID-19 and other RNA viral infections.

Authors:  James J DiNicolantonio; Mark McCarty; Jorge Barroso-Aranda
Journal:  Open Heart       Date:  2021-03

Review 6.  New Roles for Vitamin D Superagonists: From COVID to Cancer.

Authors:  David J Easty; Christine J Farr; Bryan T Hennessy
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-31       Impact factor: 5.555

Review 7.  Potential Effects of Melatonin and Micronutrients on Mitochondrial Dysfunction during a Cytokine Storm Typical of Oxidative/Inflammatory Diseases.

Authors:  Virna Margarita Martín Giménez; Natalia de Las Heras; León Ferder; Vicente Lahera; Russel J Reiter; Walter Manucha
Journal:  Diseases       Date:  2021-04-14

Review 8.  Reviewing the Significance of Vitamin D Substitution in Monoclonal Gammopathies.

Authors:  Vanessa Innao; Alessandro Allegra; Lia Ginaldi; Giovanni Pioggia; Massimo De Martinis; Caterina Musolino; Sebastiano Gangemi
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

Review 9.  Dysregulated inflammation may predispose patients with serious mental illnesses to severe COVID‑19 (Review).

Authors:  Sergej Nadalin; Hrvoje Jakovac; Vjekoslav Peitl; Dalibor Karlović; Alena Buretić-Tomljanović
Journal:  Mol Med Rep       Date:  2021-06-29       Impact factor: 2.952

10.  Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis.

Authors:  R Pal; M Banerjee; S K Bhadada; A J Shetty; B Singh; A Vyas
Journal:  J Endocrinol Invest       Date:  2021-06-24       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.